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Human umbilical vein endothelial cells (HUVECs) dysfunction in
vitro.
METHODS In vivo, obesity-related hypertensive rat models were
induced by high-fat diet for 25 weeks. The aqueous extract of TT and
telmisartan was intragastrically administrated for 8 weeks. Body
weight, blood pressure and heart rate were measured weekly to
observe the slimming beneﬁts and anti-hypertensive effects of the
drugs. The endothelial morphology of the thoracic aorta was observed
by HE staining and scanning electron microscope. The level of serum
lipid was measured by biochemical methods, and serum leptin,
AngII, ET-1, NO, NPY and Hcy was determined by ELISA. In vitro,
HUVECs were pre-incubated for 60 min with TT (30 ug/ml and 3 ug/
ml separately) or 10-5 mol/l telmisartan and then the injured
endothelium model was established by applying 100 mg/ml ox-LDL
for 24 h. Cell viability of HUVECs was observed by real-time cell
electronic sensing assay and apoptosis rate by Annexin V/PI
staining. The cell migration assay was performed with a Trans-
well insert system. Cytoskeleton remodeling was observed by
immunoﬂuorescence assay. The content of eNOS was measured by
ELISA. Intracellular reactive oxygen species (ROS) generation was
assessed by immunoﬂuorescence and ﬂow cytometer. Key genes
associated with the metabolism of ox-LDL were chosen for quanti-
tative real-time PCR to explore the possible mechanism of TT
against oxidized LDL-induced endothelial dysfunction.
RESULTS TT decreased systolic pressure, diastolic pressure, mean
arterial pressure and heart rate, and showed against weight gain ef-
fect. TT improved endothelial integrity of thoracic aorta, decreased
leptin, AngII, ET-1, NPY and Hcy, while increased NO.
In vitro, TT suppressed ox-LDL-induced HUVEC proliferation and
apoptosis rates signiﬁcantly and TT prolonged the HUVEC survival
time and postponed the cell’s decaying stage. TT improved the
endothelial cytoskeletal network and increased cell migration. Addi-
tionally, TT regulated of the synthesis of endothelial nitric oxide
synthase and generation of intracellular reactive oxygen species. TT
signiﬁcantly decreased mRNA expression of PI3Ka and Socs3. It also
increased mRNA expression of Akt1, AMPKa1, JAK2, LepR and STAT3
induced by ox-LDL. The results suggested that the JAK2/STAT3 and/or
PI3K/AKT pathway may be a very important pathway of the pharma-
cological mechanism of TT against endothelium injury.
CONCLUSIONS TT demonstrated excellent slimming beneﬁts, anti-
hypertension and endothelial protective effects. It also suggested that
the JAK2/STAT3 and/or PI3K/AKT pathway might be a very important
pathway which was involved in the pharmacological mechanism of
TT as the vascular protective agent.GW26-e3603
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OBJECTIVES The major cardiac cell type expressing HMGB1 is the
cardiac myocyte (CM) while the primary IL-33 expressing cell is
the cardiac ﬁbroblast (CF). Here we delineated the extracellular
communication pathway between cardiomyocyte and ﬁbroblast that
contributes to murine DiCM.
METHODS DM was induced in 6-week-old, male C57BL/6 mice by
intraperitoneal (i.p.) injection of streptozotocin (STZ). The sex
matched littermates were injected with an equal volume of citrate
buffer as controls (pH¼4.5). CMs or CFs cultured individually or in co-
culture were challenged with 30 mM glucose in M199 to simulate the
hyperglycemia of DM. As an osmotic control, the cells were incubated
with 30 mM mannitol in M199. Immunoﬂourescence staining and
Western blot were used for assessment of protein expression of
HMGB1, IL-33 and collagen I and III. A mouse pressure-volume loop
analysis system was used for assessment of myocardial function.
RESULTS 1) myocardial expression of HMGB1 and IL-33 were detected
by immunoﬂourescence staining and Western blot in the murine STZ
model of DM. Myocardial expression of HMGB1 was increased, while
that of IL-33 was decreased at 2 and 4 weeks after achieving a
hyperglycemic state. HMGB1 was primarily localized to the myocytes,
while IL-33 was localized to the interstitial ﬁbroblasts.
2) Mice developed cardiomyopathy six weeks after the induction of
DM as indicated by increased myocardial ﬁbrosis and dysfunction.The myocardial collagen deposition and improvement of myocardial
function were substantially attenuated by inhibition of HMGB1or
exogenous IL-33.
3) Although challenge of isolated CFs with HG increased HMGB1
production, the effects were minimal compared to those noted in CM.
In vitro HG model, cardiac myocytes can potentiate the down-regu-
lation of IL-33 in CFs; an effect mediated by myocyte-derived HMGB1.
4) HG challenge of CFs alone slightly increased collagen I ex-
pression. The effect was signiﬁcantly enhanced when CFs were
co-cultured with CMs; the potentiating effect was abrogated by the
HMGB1 inhibitor, A-box. Further, increase in collagen I expression
by isolated CFs in response to HG, was potentiated by exogenous
administration of HMGB1.
5) When TRL4-/- CFs were co-cultured with wild type CMs, the CM-
induced potentiating effect on down-regulation of CF IL-33 and in-
crease in CF collagen production was negated. Two weeks after the
induction of the STZ model, the expected decrease in IL-33 was
noted in WT mice, but ,it was not evident in TLR4-/- mice. Further， in
TLR4-/- mice, the STZ-induced myocardial ﬁbrosis and dysfunction
were blunted.
CONCLUSIONS Our data support that cardiac myocyte-ﬁbroblast
interaction plays a key role in diabetic myocardial ﬁbrosis. Specif-
ically, our study indicates myocyte HMGB1-ﬁbroblast TLR4/IL-33 axis
contributes to the development of myocardial ﬁbrosis and dysfunc-
tion in mice with diabetes.
The study was supported by a grant from the National Natural
Science Foundation of China (grant number: 81370333)
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OBJECTIVES To investigated beneﬁcial effects and its mechanisms of
naked plasmid expressing recombinant human hepatocyte growth
factor on left ventricular remodeling and dysfunction.
METHODS Acute myocardial infarction was induced male SD rats by
ligating anterior descending of left coronary artery. These rats were
randomly assigned to HGF group (n¼8); a single myocardial injection
of naked plasmid expressing HGF (250 ug/injection) immediately after
left coronary artery ligation. Control group (n¼8);myocardial injection
of same dose naked plasmid without HGF, normal group (n¼10); the
suture was passed but not tied treated. After four or eight weeks.
cardiac function was evaluated by echocardiography respectively, the
cardiacs specimens at eight-week time point were subjected to Mas-
son staining and immunohistochemical analysis.
RESULTS Four weeks later, left ventricular remodeling and dysfunc-
tion were apparent,and LV anterior wall thickness (LVAWT) were
signiﬁcantly reduced (P<0.001) in the control group. However, left
ventricular remodeling and dysfunction were signiﬁcantly relieved
(p<0.05) and LVAWT were thicker (p¼0.378) in the HGF group.
Eight weeks later, HGF-treated rats showed that left ventricular
remodeling and dysfunction were still signiﬁcantly improved
(p<0.05), furthermore ,signiﬁcant mitigation of LVAWT was seen in
HGF-treated rats (P<0.05). Eight weeks later, the infarct size signiﬁ-
cantly reduced and the infarct wall was thicker in the HGF-treated
rates (P<0.05). Myocardial ﬁbrosis was signiﬁcantly reduced and the
density of blood capillary was signiﬁcantly increased in the myocar-
dial infarcted area in HGF group (P<0.001)
CONCLUSIONS Recombinant human hepatocyte growth factor im-
proves postinfarction cardiac remodeling and dysfunction by
reducing infarct size and myocardial ﬁbrosis and increasing by density
of blood capillary.
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OBJECTIVES Diabetes is an independent risk factor of heart failure
and mortality after myocardial infarction(MI). The activity and
